temporal

Have you noticed a shift in your role as an oncology nurse?

 

We're investigating how clinical practices and management strategies have adapted, particularly through the challenges of the pandemic. Your insights are invaluable in charting the course ahead for oncology nursing.

 

Share your views in this online survey developed by a scientific committee from GI NURSES CONNECT.

 

The findings will be published to potentially drive professional development and inform future policies.

 

Complete the survey and tell us about your current and future scope of work, including:

  • Your role, responsibilities, and involvement with emerging treatments and technologies
  • How you apply and integrate the latest therapies, digital health records, remote care, and patient-first approach
  • New oncology nursing developments on the horizon
  • How you managed challenges and supported patients during the pandemic

 

If you're an oncology nurse in the USA, please spare 10-15 minutes to take the survey and have your say. All responses are anonymous.

 

Your contribution counts. Share your voice and make an impact!

Educational Objectives

  • To evaluate the current and future scope of oncology nursing practice
  • To understand the impact of COVID-19 and enhance Quality of Care
  • To drive professional development and inform policy

Natasha A. Pinheiro is an adult-gerontological primary care nurse practitioner working with the solid tumor gastrointestinal medical oncology group at Memorial Sloan Kettering Cancer Center in New York. She completed her Bachelor Science in nursing from New York University and her masters of science in nursing, adult nurse practitioner form Long Island University. Ms. Pinheiro specializes in the medical management of patients with gastrointestinal cancers, focusing on colorectal cancers with hepatic arterial infusion pump therapy, upper GI and hepatobiliary cancers. She has served on multiple HCC advisory boards and has been a member of the Nursing Advisory Board of the Cholangiocarcinoma Foundation.

Brittni has been working as an Advanced Clinical Education Specialist for UPMC Hillman Cancer Center in Pittsburgh PA since 2017. She earned her Master’s in Nursing Administration from Waynesburg University, Waynesburg PA in 2014 and her Bachelor’s in Nursing from Carlow University, Pittsburgh PA. She has been working in oncology since 2010 with her initial nursing experience in critical care. Her oncology experience includes Clinical Research, Stem Cell Transplant, Management, and Education.

Karen Waldrop Karen Waldrop received her Bachelor of Nursing Science from Florida State University in 1987. Her nursing background includes Internal Medicine, Infectious Diseases, Cardiac Stepdown, and In-patient Multidisciplinary Research. Karen has found her passion in Oncology nursing where she operated since 2011, receiving the designation of Oncology Certified Nurse in 2017. Since January, 2018 Karen has been serving as the GI Oncology Clinical Care Coordinator at the University of Alabama at Birmingham.

Nina Grenon is a nurse practitioner caring for patients with Gastrointestinal Cancers for the past 22 years, 14 at the Dana-Farber Cancer Institute and the previous 8 years at the Massachusetts General Hospital Cancer Center. She is adjunct faculty at Simmons College, School of Nursing and Health Sciences and serves as a clinical preceptor for nurse practitioner students at Yale University, Simmons College and MGH Institute of Health Professions. She serves on the North America Neuroendocrine Association Tumor Society, regional education committee. Nina Grenon is a frequent national and regional lecturer in colon and pancreatic cancer, published a number of articles in the nursing implication in the management of side effects in patients treated for colon cancer. She is currently on the Oncology Nursing Society Congress Planning Team for 2020. Her research and quality improvement interest include patient and care taker education, specific intervention delivered by front line nurses and the early integrating of palliative care in patients with advanced gastrointestinal malignancies specifically pancreatic cancer.

Programme summary
Take the survey
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Bayer.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer and from Eisai Europe Limited.

Meet the experts

Other programmes of interest

video Video
Oncology 
ER+ metastatic breast cancer: Elacestrant and beyond

Follow a patient's journey during and post-elacestrant treatment for ER+/HER2- metastatic breast cancer

Experts
Prof. Maria Vittoria Dieci
Endorsed by
GRASP
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Feb 2024

Educational programme supported by an independent medical education grant from Menarini Stemline Oncology.
podcast Podcast

Episode

3

of 3

episode
Oncology 
Ovarian Cancer: Pre-analytical phase challenges and biomarker testing

Experts
Assoc. Prof. Martina Murphy, Assoc. Prof. Caterina Marchiò, Oncology Brothers (Moderators)
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 32 MIN
  • calendar Feb 2024

Educational programme supported by an independent medical education grant from AstraZeneca and Amoy Diagnostics.
micro-learning Micro learning

Module

2

of 2

module
Oncology 
PARP inhibitors in prostate cancer and the rationale behind combination treatment

Module 2 - Evolving landscape of PARPi in mCRPC: Combination with anti-androgens

Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale Rescigno
Endorsed by
ZERO EAUN
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jan 2024

Educational programme supported by an independent medical education grant from AstraZeneca
micro-learning Micro learning

Module

1

of 2

module
Oncology 
PARP inhibitors in prostate cancer and the rationale behind combination treatment

Module 1 - PARP inhibitors in advanced prostate cancer

Experts
Assoc. Prof. Alicia Morgans, Dr Pasquale Rescigno
Endorsed by
ZERO EAUN
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Jan 2024

Educational programme supported by an independent medical education grant from AstraZeneca
interactive-patient-case Interactive patient case

Episode

2

of 2

episode
Oncology 
Advanced HCC: Treatment options for patients ineligible for IO

Explore treatment options, adverse event management and next steps in this interactive patient case

Experts
Prof. Sammy Saab
Endorsed by
Blue Faery Digestive Cancers Europe 5th anniversary
Global Liver Institute
  • clock 15 MIN
  • calendar Jan 2024

Educational programme supported by an independent medical education grant from Bayer.
podcast Podcast

Episode

2

of 3

episode
Oncology 
Lung Cancer: Pre-analytical phase challenges and biomarker testing

Moderated by the Oncology Brothers. Episode 2 of a 3-part video podcast series

Experts
Dr Bruna Pellini, Dr Semir Vranić, Oncology Brothers (Moderators)
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Jan 2024

Educational programme supported by an independent medical education grant from AstraZeneca and Amoy Diagnostics.